Sanofi India MD Rodolfo Hrosz to step down on April 30
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
Standalone profit from operations for Q4-2024 were Rs. 108 crore
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
Subscribe To Our Newsletter & Stay Updated